Patents by Inventor Stephanie Krammer-Lukas

Stephanie Krammer-Lukas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treating conditions associated with increased eotaxin with 25-hydroxyvitamin D3
    Patent number: 10357501
    Abstract: Methods for treating/preventing conditions associated with an increased level of eotaxin in a human with 25-hydroxyvitamin D3 (calcifediol) are provided. Optionally, vitamin D3 may be used together with 25-hydroxyvitamin D3.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: July 23, 2019
    Assignee: DSM IP ASSETS B.V.
    Inventors: Stephanie Krammer-Lukas, Elisabeth Stoecklin, Joseph Schwager, Swen Wolfram
  • TREATING CONDITIONS ASSOCIATED WITH INCREASED EOTAXIN WITH 25-HYDROXYVITAMIN D3
    Publication number: 20170106005
    Abstract: Methods for treating/preventing conditions associated with an increased level of eotaxin in a human with 25-hydroxyvitamin D3 (calcifediol) are provided. Optionally, vitamin D3 may be used together with 25-hydroxyvitamin D3.
    Type: Application
    Filed: December 28, 2016
    Publication date: April 20, 2017
    Inventors: Stephanie KRAMMER-LUKAS, Elisabeth STOECKLIN, Joseph SCHWAGER, Swen WOLFRAM
  • TREATING CONDITIONS ASSOCIATED WITH INCREASED EOTAXIN WITH 25-HYDROXYVITAMIN D3
    Publication number: 20130252927
    Abstract: The present invention relates to treating/preventing conditions associated with an increased level of eotaxin in a human with 25-hydroxyvitamin D3 (calcifediol). Optionally, vitamin D3 may be used together with 25-hydroxyvitamin D3.
    Type: Application
    Filed: December 5, 2011
    Publication date: September 26, 2013
    Applicant: DSM IP ASSETS, B.V.
    Inventors: Stephanie Krammer-Lukas, Elisabeth Stoecklin, Joseph Schwager, Swen Wolfram